Lactoferrin Exerts Antitumor Effects by Inhibiting Angiogenesis in a HT29 Human Colon Tumor Model

Journal of Agricultural and Food Chemistry

Volumn 65, Issue 48, 2017, Pages 10464-10472

  Li, Hui Ying ^a   Li, Ming ^a   Luo, Chao Chao ^a   Wang, Jia Qi ^a   Zheng, Nan ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

angiogenesis; HCT8 cell; HT29 cell; lactoferrin; tumor bearing model

Indexed keywords

BLOOD VESSELS; CELL CULTURE; CELL PROLIFERATION; CELLS; TUMORS;

ANGIOGENESIS; ANTITUMOR EFFECT; BEARING MODELING; COLON CANCER CELLS; DOSE-DEPENDENT MANNER; HT-29 CELLS; LACTOFERRIN; POTENTIAL MECHANISM;

CYTOLOGY;

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; LACTOFERRIN;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; COLON TUMOR; DISEASE MODEL; DRUG EFFECTS; DRUG SCREENING; HT-29 CELL LINE; HUMAN; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOPHYSIOLOGY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HT29 CELLS; HUMANS; LACTOFERRIN; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85037528856     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.7b03390     Document Type: Article

References (64)

1. O'Brien, C. A.; Pollett, A.; Gallinger, S.; Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007, 445, 106-110 10.1038/nature05372
2. Mandel, J. S.; Bond, J. H.; Church, T. R.; Snover, D. C.; Bradley, G. M.; Schuman, L. M.; Ederer, F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N. Engl. J. Med. 1993, 328, 1365-1371 10.1056/NEJM199305133281901
3. Weisburger, J. H. Causes, relevant mechanisms, and prevention of large bowel cancer Semin. Oncol. 1991, 18, 316-336
4. Klaver, C. E.; Gietelink, L.; Bemelman, W. A.; Wouters, M. W.; Wiggers, T.; Tollenaar, R. A.; Tanis, P. J. Locally Advanced Colon Cancer: Evaluation of Current Clinical Practice and Treatment Outcomes at the Population Level J. Natl. Compr. Cancer Network 2017, 15, 181-190 10.6004/jnccn.2017.0019
5. Ren, Q. G.; Huang, T.; Yang, S. L.; Hu, J. L. Colon cancer metastasis to the mandibular gingiva with partial occult squamous differentiation: A case report and literature review Mol. Clin. Oncol. 2017, 6, 189-192 10.3892/mco.2016.1102
6. Friis, S.; Riis, A. H.; Erichsen, R.; Baron, J. A.; Sorensen, H. T. Associations between the use of low-dose aspirin or nonsteroidal anti-inflammatory drugs and colorectal cancer risk Ann. Intern. Med. 2015, 163, 347-355 10.7326/M15-0039
7. Fajardo, A. M.; Piazza, G. A. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention Am. J. Physiol. Gastrointest Liver Physiol. 2015, 309, 59-70 10.1152/ajpgi.00101.2014
8. Gianola, F. J.; Sugarbaker, P. H.; Barofsky, I.; White, D. E.; Meyers, C. E. Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer Am. J. Clin. Oncol. 1986, 9, 403-410 10.1097/00000421-198610000-00009
9. Pfütze, K.; Benner, A.; Hoffmeister, M.; Jansen, L.; Yang, R.; Bläker, H.; Herpel, E.; Ulrich, A.; Ulrich, C. M.; Chang-Claude, J.; Brenner, H.; Burwinkel, B. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy Genomics 2015, 106, 348-354 10.1016/j.ygeno.2015.10.002
10. Chen, J.; Lu, H.; Yan, D.; Cui, F.; Wang, X.; Yu, F.; Xue, Y.; Feng, X.; Wang, J.; Wang, X.; Jiang, T.; Zhang, M.; Zhao, S.; Yu, Y.; Tang, H.; Peng, Z. PAK6 increase chemoresistance and is a prognostic marker for stage II and III colon cancer patients undergoing 5-FU based chemotherapy Oncotarget 2015, 6, 355-367 10.18632/oncotarget.2803
11. Neville, M. C. Lactoferrin Secretion into Milk: Comparison between bovine, murine and human milk J. Anim. Sci. 2000, 78, 26-35 10.2527/2000.78suppl-326x
12. Chung, S. H.; Kang, H. B.; Kim, J. W.; Yoon, S. S.; Nam, M. S. The Biological Effects of Bovine Lactoferrin on Inflammatory Cytokine Expression in the PMA Stimulated Cells Korean J. Food Sci. An. 2012, 32, 364-368 10.5851/kosfa.2012.32.3.364
13. Okubo, K.; Kamiya, M.; Urano, Y.; Nishi, H.; Herter, J. M.; Mayadas, T.; Hirohama, D.; Suzuki, K.; Kawakami, H.; Tanaka, M.; Kurosawa, M.; Kagaya, S. Lactoferrin Supresses Neutrophil Extracellular Traps Release in Inflammation EBioMedicine 2016, 10, 204-215 10.1016/j.ebiom.2016.07.012
14. Redwan, E. M.; El-Baky, N. A.; Al-Hejin, A. M.; Baeshen, M. N.; Almehdar, H. A.; Elsaway, A.; Gomaa, A. B.; Al-Masaudi, S. B.; Al-Fassi, F. A.; AbuZeid, I. E.; Uversky, V. N. Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) Res. Microbiol. 2016, 167, 480-491 10.1016/j.resmic.2016.04.006
15. González-Chávez, S. A.; Arévalo-Gallegos, S.; Rascón-Cruz, Q. Lactoferrin: structure, function and applications Int. J. Antimicrob. Agents 2008, 33, 1-8 10.1016/j.ijantimicag.2008.07.020
16. Artym, J.; Zimecki, M.; Paprocka, M.; Kruzel, M. L. Orally administered lactoferrin restores humoral immune response in immunocompromised mice Immunol. Lett. 2003, 89, 9-15 10.1016/S0165-2478(03)00102-0
17. Legrand, D. Overview of Lactoferrin as a Natural Immune Modulator J. Pediatr. 2016, 173, 10-15 10.1016/j.jpeds.2016.02.071
18. Donovan, S. M. The Role of Lactoferrin in Gastrointestinal and Immune Development and Function: A Preclinical Perspective J. Pediatr. 2016, 173, 16-28 10.1016/j.jpeds.2016.02.072
19. Sun, J.; Ren, F.; Xiong, L.; Zhao, L.; Guo, H. Y. Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL/6J mice J. Funct. Foods 2016, 22, 189-200 10.1016/j.jff.2016.01.022
20. Chen, Q. Z.; Li, Y.; Shao, Y.; Zeng, Y. H.; Ren, W. Y.; Liu, R. X.; Zhou, L. Y.; Hu, X. L.; Huang, M.; He, F.; Sun, W. J.; Wu, K.; He, B. C. TGF-β1/PTEN/PI3K signaling plays a critical role in the anti-proliferation effect of tetrandrine in human colon cancer cells Int. J. Oncol. 2017, 50, 1011-1021 10.3892/ijo.2017.3875
21. Zhao, M.; Yu, Z.; Li, Z.; Tang, J.; Lai, X.; Liu, L. Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism Oncol. Rep. 2017, 37, 601-607 10.3892/or.2016.5231
22. Parnaud, G.; Li, P. F.; Cassar, G.; Rouimi, P.; Tulliez, J.; Combaret, L.; Gamet-Payrastre, L. Mechanism of Sulforaphane-Induced Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells Nutr. Cancer 2009, 48, 198-206 10.1207/s15327914nc4802-10
23. Pai, R.; Soreghan, B.; Szabo, I. L.; Pavelka, M.; Baatar, D.; Tarnawski, A. S. Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy Nat. Med. 2002, 8, 289-293 10.1038/nm0302-289
24. Jiang, R. L.; Lonnerdal, B. Bovine lactoferrin and bovine lactoferricin are internalized by colon cancer cells and exhibit elevated apoptosis FASEB 2016, 26, 366.8
25. Moastafa, T. M.; Aee, E. S.; Elsaeed, G. K.; Mse, K. Corrigendum to "Study on the therapeutic benefit on lactoferrin in patients with colorectal cancer receiving chemotherapy Int. Scholarly Res. Not. 2015, 2015, 1-3 10.1155/2015/424603
26. Jiang, R.; Lönnerdal, B. Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways Biochem. Cell Biol. 2017, 95, 99-109 10.1139/bcb-2016-0094
27. Fedorka, C. E.; Scoggin, K. E.; Woodward, E. M.; Squires, E. L.; Ball, B. A.; Troedsson, M. H. T. Exogenous lactoferrin suppresses the mRNA expression of the pro-inflammatory cytokine tumor necrosis factor (TNF) in mares susceptible to persistent mating-induced endometritis J. Equine. Vet. Sci. 2016, 43, 56-82 10.1016/j.jevs.2016.06.046
28. Jin, S.; Zuo, X.; Li, H. Inhibition of DMH-DSS-induced colorectal cancer by lactoferrin in rats Acta Med. Sin. 2016, 29, 18-21
29. Guillén, C.; McInnes, I. B.; Vaughan, D. M.; Kommajosyula, S.; Van, B. P. H.; Leung, B. P.; Aguila, A.; Brock, J. H. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice J. Immunol. 2002, 168, 3950-3957 10.4049/jimmunol.168.8.3950
30. Legrand, D.; Elass, E.; Pierce, A.; Mazurier, J. Lactoferrin and host defence: an overview of its immuno-modulating and anti-inflammatory properties BioMetals 2004, 17, 225-229 10.1023/B:BIOM.0000027696.48707.42
31. Damiens, E.; Mazurier, J.; el Yazidi, I.; Masson, M.; Duthille, I.; Spik, G.; Boilly-Marer, Y. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells Biochim. Biophys. Acta, Mol. Cell Res. 1998, 1402, 277-287 10.1016/S0167-4889(98)00013-5
32. Spadaro, M.; Curcio, C.; Varadhachary, A.; Cavallo, F.; Engelmayer, J.; Blezinger, P.; Pericle, F.; Forni, G. Requirement for IFN-γ, CD8+ T Lymphocytes, and NKT Cells in talactoferrin-induced inhibition of neu+ tumors Cancer Res. 2007, 67, 6425-6432 10.1158/0008-5472.CAN-06-4080
33. Farley, J.; Loup, D.; Nelson, M.; Mitchell, A.; Esplund, G.; Macri, C.; Harrison, C.; Gray, K. Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression Mol. Carcinog. 1997, 20, 240-250 10.1002/(SICI)1098-2744(199710)20:2<240::AID-MC11>3.0.CO;2-A
34. Rado, T. A.; Wei, X. P.; Jr, B. E. Isolation of lactoferrin cDNA from a human myeloid library and expression of m RNA during normal and leukemic myelopoiesis Blood 1987, 70, 989-993
35. Damiens, E.; Ikram, E. Y.; Joël, M.; Elisabeth, E. R.; Isabelle, D.; Geneviève, S.; Yolande, B. M. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line Eur. J. Cell Biol. 1998, 77, 344-351 10.1016/S0171-9335(98)80093-9
36. Xiao, Y.; Monitto, C. L.; Minhas, K. M.; Sidransky, D. Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells Clin. Cancer Res. 2004, 10, 8683-8686 10.1158/1078-0432.CCR-04-0988
37. Lee, S. H.; Park, S. W.; Pyo, C. W.; Yoo, N. K.; Kim, J.; Choi, S. Y. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line Biochimie 2009, 91, 102-108 10.1016/j.biochi.2008.05.004
38. Fujita, K.; Matsuda, E.; Sekine, K.; Iigo, M.; Tsuda, H. Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat Cancer Lett. 2004, 213, 21-29 10.1016/j.canlet.2004.03.029
39. Mulder, A. M.; Connellan, P. A.; Oliver, C. J.; Morris, C. A.; Stevenson, L. M. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males Nutr. Res. (N. Y., NY, U. S.) 2008, 28, 583-589 10.1016/j.nutres.2008.05.007
40. Moser, A. R.; Pitot, H. C.; Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse Science 1990, 247, 322-324 10.1126/science.2296722
41. Kanwar, J. R.; Palmano, K. P.; Sun, X. Y.; Kanwar, R. K.; RitaGupta, H. N.; Rowan, A.; Ram, S.; Krissansen, G. W. Iron-saturated lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy Immunol. Cell Biol. 2008, 86, 277-288 10.1038/sj.icb.7100163
42. Artym, J.; Zimecki, M.; Paprocka, M.; Kruzel, M. L. Orally administered lactoferrin restores humoral immune response in immunocompromised mice Immunol. Lett. 2003, 89, 9-15 10.1016/S0165-2478(03)00102-0
43. Roy, K.; Patel, Y. S.; Kanwar, R. K.; Rajkhowa, R.; Wang, X.; Kanwar, J. R. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells Int. J. Nanomed. 2015, 11, 25-44 10.2147/IJN.S91810
44. Gibbons, J. A.; Kanwar, J. R.; Kanwar, R. K. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer BMC Cancer 2015, 15, 425-434 10.1186/s12885-015-1441-4
45. Norrby, K. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo J. Vasc. Res. 2004, 41, 293-304 10.1159/000078927
46. Amouric, M.; Marvaldi, J.; Pichon, J.; Bellot, F.; Figarella, C. Effect of lactoferrin on the growth of a human colon adenocarcinoma cell line-comparison with transferrin In Vitro 1984, 20, 543-548 10.1007/BF02639770
47. Xu, M.; Wang, S.; Song, Y. U.; Yao, J.; Huang, K.; Zhu, X. Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway Oncol. Lett. 2016, 11, 3075-3080 10.3892/ol.2016.4331
48. Miao, L.; Xiong, X.; Lin, Y.; Cheng, Y.; Lu, J.; Zhang, J.; Cheng, N. MiR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells Oncol. Lett. 2014, 7, 658-662 10.3892/ol.2014.1807
49. Zhang, N.; Chen, W. J.; Liu, Q. Q.; Zhou, Y.; Zhong, R. G. Studies on Radical Scavenging and Anti-tumor Effects of Coumarins Food Res. Dev. 2016, 37, 1-5
50. Murakami, A.; Ohigashi, H.; Koshimizu, K. Anti-tumor promotion with food phytochemicals: a strategy for cancer chemoprevention Biosci., Biotechnol., Biochem. 1996, 60, 1-8 10.1271/bbb.60.1
51. Li, D.; Chen, Y. Y.; Huang, Y. H.; Zhang, L. J.; Yang, J. G.; Xu, X. G.; Liu, Q.; Zhang, X. Study on the Anti-Tumor Ability of Niaowangzhong Green Tea J. Food Biochem. 2017, 41, e12305 10.1111/jfbc.12305
52. Ji, X.; Shen, Y.; Sun, H.; Gao, X. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel Tumor Biol. 2016, 37, 1-12 10.1007/s13277-016-4803-x
53. Liu, M.; Qi, Z.; Liu, B.; Ren, Y.; Li, H.; Yang, G.; Zhang, Q. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway Oncotarget 2015, 6, 25281-25294 10.18632/oncotarget.4634
54. Cragg, G. M.; Grothaus, P. G.; Newman, D. J. Impact of natural products on developing new anti-cancer agents Chem. Rev. 2009, 109, 3012-3043 10.1021/cr900019j
55. Marone, G.; Varricchi, G.; Loffredo, S.; Granata, F. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis Eur. J. Pharmacol. 2016, 778, 146-151 10.1016/j.ejphar.2015.03.088
56. Marone, G.; Borriello, F.; Varricchi, G.; Genovese, A.; Granata, F. Basophils: historical reflections and perspectives Chem. Immunol. Allergy 2014, 100, 172-192 10.1159/000358734
57. Ferrara, N. Vascular endothelial growth factor: pathophysiology and clinical implications. In Angiogenesis. From Basic Science to Clinical Applications; Ferrara, N., Ed.; CRC: New York, 2007; pp 1-36.
58. Roiron-Lagroux, D.; Figarella, C. Further evidence of different lactoferrin and transferrin binding sites on human HT29-D4 cells. Effects of lysozyme, fucose and cathepsin G. Comparison with transferrin Biochim. Biophys. Acta, Mol. Cell Res. 1994, 1224, 441-444 10.1016/0167-4889(94)90280-1
59. Marone, G.; Galdiero, M. R.; Melillo, R. M. Mast cells and basophils in angiogenesis: bridging the gap between inflammation and tumors. Pacini Editore; Pisa, 2012; pp 21-35.
60. Meng, Y. C.; Ding, Z. Y.; Wang, H. Q.; Ning, L. P.; Wang, C. Effect of microRNA-155 on angiogenesis after cerebral infarction of rats through AT1R/VEGFR2 pathway. Asian Pac Asian Pac. J. Trop. Med. 2015, 8, 829-835 10.1016/j.apjtm.2015.09.009
61. Silpanisong, J.; Pearce, W. J. Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling Curr. Vasc. Pharmacol. 2013, 11, 544-563 10.2174/1570161111311050002
62. Ritchie, D. W.; Grudinin, S. Spherical Polar Fourier Assembly of Protein Complexes with Arbitrary Point Group Symmetry J. Appl. Crystallogr. 2016, 49, 158-167 10.1107/S1600576715022931
63. Ghoorah, A. W.; Devignes, M. D.; Smaïltabbone, M.; Ritchie, D. W. Protein docking using case-based reasoning Proteins: Struct., Funct., Genet. 2013, 81, 2150-2158 10.1002/prot.24433
64. Ritchie, D. W.; Venkatraman, V. Ultra-fast FFT protein docking on graphics processors Bioinformatics 2010, 26, 2398-2405 10.1093/bioinformatics/btq444